Marrissa Martyn-St James
Overview
Explore the profile of Marrissa Martyn-St James including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
52
Citations
1225
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Cartledge A, Hind D, Bradburn M, Martyn-St James M, Davenport S, Tung W, et al.
Br J Anaesth
. 2022 Aug;
129(4):567-580.
PMID: 35934529
Background: Epidural-related maternal fever in women in labour has consequences for the mother and neonate. There has been no systematic review of preventive strategies. Methods: RCTs evaluating methods of preventing...
2.
Ferentinos P, Tsakirides C, Swainson M, Davison A, Martyn-St James M, Ispoglou T
Eur J Appl Physiol
. 2022 Mar;
122(7):1589-1625.
PMID: 35305142
Objectives: to systematically examine the acute and chronic effects of different forms of exercise on circulating EPCs in healthy populations. Methods: Preferred Reporting Items for Systematic Reviews and Meta-analyses guidelines...
3.
Poku E, Harnan S, Rooney G, Martyn-St James M, Hernandez-Alava M, Schaufler T, et al.
Clin Kidney J
. 2022 Feb;
15(3):484-499.
PMID: 35211305
Background: Chronic kidney disease-associated pruritus (CKD-aP) is a common and burdensome condition for end-stage kidney disease (ESKD) patients, especially those receiving haemodialysis. High-quality evidence of the relationship between CKD-aP and...
4.
Rafia R, Martyn-St James M, Harnan S, Metry A, Hamilton J, Wailoo A
Value Health
. 2022 Feb;
25(5):761-769.
PMID: 35197225
Objectives: COVID-19 is associated with significant morbidity and mortality. This study aims to synthesize evidence to assess the cost-effectiveness of remdesivir (RDV) for the treatment of hospitalized patients with COVID-19...
5.
Ferentinos P, Tsakirides C, Swainson M, Davison A, Martyn-St James M, Ispoglou T
Eur J Appl Physiol
. 2022 Jan;
122(4):815-860.
PMID: 35022875
Objectives: to systematically examine the acute and chronic effects of different exercise modalities on circulating EPCs in patients with cardiovascular and metabolic disease. Methods: Preferred Reporting Items for Systematic Reviews...
6.
Scott A, Webb T, Martyn-St James M, Rowse G, Weich S
Sleep Med Rev
. 2021 Oct;
60:101556.
PMID: 34607184
The extent to which sleep is causally related to mental health is unclear. One way to test the causal link is to evaluate the extent to which interventions that improve...
7.
Davis S, Simpson E, Hamilton J, Martyn-St James M, Rawdin A, Wong R, et al.
Health Technol Assess
. 2020 Jun;
24(29):1-314.
PMID: 32588816
Background: Fragility fractures are fractures that result from mechanical forces that would not ordinarily result in fracture. Objectives: The objectives were to evaluate the clinical effectiveness, safety and cost-effectiveness of...
8.
Martyn-St James M, Faria R, Wong R, Scope A
Br J Clin Pharmacol
. 2020 May;
87(1):42-75.
PMID: 32424902
This was a rapid review of systematic reviews (SRs) on problematic polypharmacy (PP) in the UK. The commissioner-defined topics were burden of PP, interventions to reduce PP, implementation activities to...
9.
Perry A, Martyn-St James M, Burns L, Hewitt C, Glanville J, Aboaja A, et al.
Cochrane Database Syst Rev
. 2019 Dec;
12:CD010910.
PMID: 31834635
Background: This review represents one in a family of three reviews focusing on the effectiveness of interventions in reducing drug use and criminal activity for offenders. Objectives: To assess the...
10.
Simpson E, Martyn-St James M, Hamilton J, Wong R, Gittoes N, Selby P, et al.
Bone
. 2019 Oct;
130:115081.
PMID: 31626995
Objectives: To determine the clinical effectiveness of denosumab (DEN), raloxifene (RLX), romosozumab (ROMO) and teriparatide (TPTD), within their licensed (or anticipated licensed) indications, for the treatment of osteoporosis. Methods: A...